A vaccine against fentanyl—a drug contributing to the opioid crisis gripping the U.S.—appears to have put rats off the substance in a study.
Between 2010 and 2016, there was a 493 percent spike in people being diagnosed with opioid addiction, in what the National Institute of Drug Abuse describes as a national crisis. In that time, deaths caused by fentanyl hit 19,413 a year, amounting to a 646 percent increase since 2010. The synthetic opioid is up to 50 times stronger than heroin, and has been sold by drug dealers because of its high profit margin compared with other opioids.
The crisis has seen lawmakers and scientists double-down on efforts to tackle addiction and gain a deeper understanding of the condition.
Dr. Matthew L. Banks, associate professor of pharmacology and toxicology at VCU School of Medicine, and professor Kim D. Janda of The Scripps Research Institute co-authored a study published in the journal Neuropsychopharmacology.
They commented: “One strategy includes using opioid-targeted vaccines to elicit antibody production by the host’s immune system that recognizes and block the passage of a specific opioid into the brain and peripheral organs/tissue.”
Their research looked at immunopharmacotherapies: or drugs that work against substances like fentanyl to stop addiction. Such treatments don’t appear to cause bad side effects and they are specific to particular substances, meaning patients can be treated with other painkillers in a medical setting if needs be, the authors explained.
The scientists created a vaccine designed to stop rats from craving fentanyl by triggering an immune response against the drug. To test it, they dosed mice addicted to fentanyl twice over a three-week period, with either the experimental vaccine or two medications currently used to treat substance addiction (naltrexone and clonidine). The team documented whether the rats would seek out fentanyl or food after taking the medicine.
Rats who took the vaccine were more likely to choose food over fentanyl for 15 weeks after being administered with the vaccine, the scientists showed in their paper.
But as the drug was tested in rats, it is unclear whether it is safe for, or will work in, humans. Also, as the authors stated in their study, individuals need strong immune systems for the drug to work. It can also take weeks for the vaccine to reach its full potential.
Earlier this year, a separate study published in the journal JAMA Network Open looking at the causes of the opioid crisis linked painkiller marketing aimed at physicians to higher numbers of overdoses.
- Fentanyl Changed the Opioid Epidemic. Now It’s Getting Worse
- Scripps researcher developing vaccine to battle heroin addiction
- Only 1 Percent of People Become Chronic Opioid Users After Hospital Prescriptions for Injuries, Study Shows
- An Alarming Number of Kids Are Getting Their Hands on Opioids
- National wastewater analysis shows high use of opioid painkillers in Canberra
- Opioid Complications Are Related to the Dose
- Prescription Opioids Create a Societal Problem
- US faces worst measles outbreak in nearly three decades
- Kratom, the Herb of Last Resort for Recovering Addicts, Is in Legal Trouble
- CBD oil is the new rage among millennials. But, as a doctor, here's what I worry about
- Elbow’s Guy Garvey reveals band’s dark new album ‘reflects the unsettled nature of the country being divided by Brexit’
- Doctors in marginalised areas doing more than just treating ailments
- Nature up close: The largest bat colony in the world
- CBD: 6 key questions answered about the marijuana extract
- Deadly Trend: Cheap, Synthetic Pot Claims Hundreds of Victims in US Capital
Fentanyl Vaccine Put Rats off Opioid in Study have 570 words, post on www.newsweek.com at April 30, 2019. This is cached page on Konitono.News. If you want remove this page, please contact us.